Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Letavic

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitorsMichael A Letavic, Emily M Stocking, Ann J Barbier, et al.
The Journal of Organic Chemistry|June 12, 2010
Synthesis of a histamine H(3) receptor antagonist-manipulation of hydroxyproline stereochemistry, desymmetrization of homopiperazine, and nonextractive sodium triacetoxyborohydride reaction workupDaniel J Pippel, Lana K Young, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2007
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitorsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibitionKevin D Jerome, Paul V Rucker, Li Xing, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2015
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.
European Journal of Pharmacology|September 20, 2015
A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334Brian Lord, Michael K Ameriks, Qi Wang, et al.
The Journal of Antibiotics|June 26, 2004
In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogensLaura J L Norcia, Annette M Silvia, Sheryl L Santoro, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitorsMichael A Letavic, Emily M Stocking, Ann J Barbier, et al.
The Journal of Organic Chemistry|June 12, 2010
Synthesis of a histamine H(3) receptor antagonist-manipulation of hydroxyproline stereochemistry, desymmetrization of homopiperazine, and nonextractive sodium triacetoxyborohydride reaction workupDaniel J Pippel, Lana K Young, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2007
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitorsMichael A Letavic, John M Keith, Kiev S Ly, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibitionKevin D Jerome, Paul V Rucker, Li Xing, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modelingScott D Bembenek, John M Keith, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2015
Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.
ACS Chemical Neuroscience|January 12, 2016
Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat BrainChrista C Chrovian, Akinola Soyode-Johnson, Hong Ao, et al.
European Journal of Pharmacology|September 20, 2015
A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334Brian Lord, Michael K Ameriks, Qi Wang, et al.
The Journal of Antibiotics|June 26, 2004
In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogensLaura J L Norcia, Annette M Silvia, Sheryl L Santoro, et al.
Pageof 6